{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:25:17Z","timestamp":1787505917380,"version":"build-2736575974"},"reference-count":28,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2003,3,3]],"date-time":"2003-03-03T00:00:00Z","timestamp":1046649600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["pathsocjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pathology"],"published-print":{"date-parts":[[2003,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cyclin E amplification and overexpression have recently been described in several tumour types. However, many tumour entities have never been examined for cyclin E alterations. Numerous and time\u2010consuming experiments were previously required to determine the significance of potential oncogenes across different tumour types. To overcome this problem, tissue microarrays (TMAs) consisting of 3670 primary tumours from 128 different tumour types, 709 metastases, and 354 normal tissues were generated. Cyclin E alterations were then analysed by fluorescence\n                    <jats:italic>in situ<\/jats:italic>\n                    hybridization (FISH) and immunohistochemistry (IHC). Cyclin E gene amplification was observed in 15 different tumour types and subtypes, ie rhabdomyosarcoma, urinary bladder cancer (three subtypes), ovarian cancer (two subtypes), malignant fibrous histiocytoma, adenocarcinoma of the small intestine, medullary breast cancer, gall bladder adenocarcinoma, phaeochromocytoma, gastric adenocarcinoma, squamous cell carcinoma of the uterine cervix, colonic adenocarcinoma, and endometrial carcinoma. Cyclin E protein accumulation was found in 48 different tumour types. The use of TMA technology has enabled us to expand considerably our knowledge of cyclin E alterations in human tumours. The occurrence of amplification and overexpression in many different tumour types suggests that cyclin E plays an important role in tumour biology. Copyright \u00a9 2003 John Wiley &amp; Sons, Ltd.\n                  <\/jats:p>","DOI":"10.1002\/path.1356","type":"journal-article","created":{"date-parts":[[2003,7,2]],"date-time":"2003-07-02T06:02:58Z","timestamp":1057125778000},"page":"375-382","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Cyclin E overexpression and amplification in human tumours"],"prefix":"10.1002","volume":"200","author":[{"given":"Peter","family":"Schraml","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Bucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Bissig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Nocito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Wilber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Seelig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Kononen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Mihatsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Dirnhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,3,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.15.5.2612"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90044-Y"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.14.3.1669"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64592-0"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910620107"},{"key":"e_1_2_6_7_2","first-page":"7021","article-title":"Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon","volume":"60","author":"Lin L","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_6_8_2","first-page":"1049","article-title":"[Mutation frequency of the p16\/CDKN2 gene and amplification of the cyclin E gene in human primary gastric carcinomas]","volume":"54","author":"Sasaki H","year":"1996","journal-title":"Nippon Rinsho"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1995.tb02442.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19960822)69:4<247::AID-IJC1>3.0.CO;2-X"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.3.1112"},{"key":"e_1_2_6_12_2","first-page":"1238","article-title":"In vivo cyclin E expression as a marker for early cervical neoplasia","volume":"11","author":"Quade BJ","year":"1998","journal-title":"Mod Pathol"},{"key":"e_1_2_6_13_2","first-page":"1661","article-title":"Immunohistochemical study of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma","volume":"18","author":"Ito K","year":"1998","journal-title":"Anticancer Res"},{"key":"e_1_2_6_14_2","first-page":"1947","article-title":"Immunohistochemical characterization of p57KIP2 expression in human esophageal squamous cell carcinoma","volume":"20","author":"Matsumoto M","year":"2000","journal-title":"Anticancer Res"},{"key":"e_1_2_6_15_2","first-page":"983","article-title":"Expression of p27Kip1, cyclin E and E2F\u20101 in primary and metastatic tumors of gastric carcinoma","volume":"6","author":"Yasui W","year":"1999","journal-title":"Oncol Rep"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01226270"},{"key":"e_1_2_6_17_2","first-page":"93","article-title":"Cyclin E overexpression in human gallbladder carcinomas","volume":"6","author":"Eguchi N","year":"1999","journal-title":"Oncol Rep"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300114"},{"key":"e_1_2_6_19_2","first-page":"4159","article-title":"Expression of cell cycle\u2010regulated proteins in prostate cancer","volume":"56","author":"Mashal RD","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<370::AID-IJC13>3.0.CO;2-A"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000028068"},{"key":"e_1_2_6_22_2","first-page":"11","article-title":"Cyclin E expression, a potential prognostic marker for non\u2010small cell lung cancers","volume":"6","author":"Mishina T","year":"2000","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_23_2","first-page":"1007","article-title":"Prognostic significance of cyclin expression in human osteosarcoma","volume":"12","author":"Molendini L","year":"1998","journal-title":"Int J Oncol"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-199904000-00006"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980610)76:6<806::AID-IJC7>3.0.CO;2-1"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.3.770"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0798-844"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1279"},{"key":"e_1_2_6_29_2","first-page":"1966","article-title":"Tissue microarrays for gene amplification surveys in many different tumor types","volume":"5","author":"Schraml P","year":"1999","journal-title":"Clin Cancer Res"}],"container-title":["The Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpath.1356","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pathsocjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/path.1356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:45:16Z","timestamp":1761047116000},"score":1,"resource":{"primary":{"URL":"https:\/\/pathsocjournals.onlinelibrary.wiley.com\/doi\/10.1002\/path.1356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["10.1002\/path.1356"],"URL":"https:\/\/doi.org\/10.1002\/path.1356","archive":["Portico"],"relation":{},"ISSN":["0022-3417","1096-9896"],"issn-type":[{"value":"0022-3417","type":"print"},{"value":"1096-9896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,3]]},"assertion":[{"value":"2002-05-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-01-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-03-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}